|
Quotes & Info
|
| APRI > SEC Filings for APRI > Form 8-K on 12-Feb-2013 | All Recent SEC Filings |
12-Feb-2013
Other Events, Financial Statements and Exhibits
On February 12, 2013, Steve Martin, Interim Chief Executive Officer and Chief Financial Officer of Apricus Biosciences, Inc. (the "Company"), delivered a corporate presentation at the BIO CEO & Investor Conference. The slides from the presentation are filed herewith as Exhibit 99.1. The Company does not undertake to update this presentation.
(d) Exhibits.
Exhibit No. Description
99.1 Corporate Presentation, dated February 12, 2013
|
|